AbbVie Inc. is 35.8x more valuable than DR REDDYS LABORATORIES LTD by market capitalization ($397.44 B vs $11.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RDY | ABBV |
|---|---|---|
| Market cap | $11.09 B | $397.44 B |
| US-listed rank | #890 | #28 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | - | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 1,301 | 1,008 |
AbbVie Inc. is 35.8x more valuable than DR REDDYS LABORATORIES LTD by market capitalization ($397.44 B vs $11.09 B).
Full pages: DR REDDYS LABORATORIES LTD and AbbVie Inc., or browse the full rankings.